430 related articles for article (PubMed ID: 34848046)
1. [Spheroids to organoids: Solid cancer models for anticancer drug discovery].
Alzeeb G; Corcos L; Le Jossic-Corcos C
Bull Cancer; 2022 Jan; 109(1):49-57. PubMed ID: 34848046
[TBL] [Abstract][Full Text] [Related]
2. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
3. 3D modeling in cancer studies.
Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
[TBL] [Abstract][Full Text] [Related]
4. [Normal organoids and their applications in cancer research].
Delom F; Le Morvan V; Robert J; Fessart D
Bull Cancer; 2022 Jan; 109(1):58-64. PubMed ID: 34903368
[TBL] [Abstract][Full Text] [Related]
5. MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery.
Wang Y; Hummon AB
J Biol Chem; 2021 Oct; 297(4):101139. PubMed ID: 34461098
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
7. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
Pamarthy S; Sabaawy HE
Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
[TBL] [Abstract][Full Text] [Related]
8. [3D Tumor organoid models produced by cellular capsules technology CCT].
Recher G; Mombereau A; Boyreau A; Nassoy P; Andrique L
Bull Cancer; 2022 Jan; 109(1):38-48. PubMed ID: 34996600
[TBL] [Abstract][Full Text] [Related]
9. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
10. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
Li W; Zhou Z; Zhou X; Khoo BL; Gunawan R; Chin YR; Zhang L; Yi C; Guan X; Yang M
Adv Healthc Mater; 2023 Jul; 12(18):e2202609. PubMed ID: 36917657
[TBL] [Abstract][Full Text] [Related]
11. Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling.
Thakuri PS; Liu C; Luker GD; Tavana H
Adv Healthc Mater; 2018 Mar; 7(6):e1700980. PubMed ID: 29205942
[TBL] [Abstract][Full Text] [Related]
12. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
13. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening.
Castro F; Leite Pereira C; Helena Macedo M; Almeida A; José Silveira M; Dias S; Patrícia Cardoso A; José Oliveira M; Sarmento B
Adv Drug Deliv Rev; 2021 Aug; 175():113824. PubMed ID: 34090966
[TBL] [Abstract][Full Text] [Related]
14. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
15. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and molecular differences of anticancer agents on 2D and 3D cell culture.
Alwahsh M; Al-Doridee A; Jasim S; Awwad O; Hergenröder R; Hamadneh L
Mol Biol Rep; 2024 Jun; 51(1):721. PubMed ID: 38829450
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
Calpe B; Kovacs WJ
Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
[TBL] [Abstract][Full Text] [Related]
18. Using 3D in vitro cell culture models in anti-cancer drug discovery.
Langhans SA
Expert Opin Drug Discov; 2021 Aug; 16(8):841-850. PubMed ID: 33823728
[TBL] [Abstract][Full Text] [Related]
19. Recapitulating Tumor Microenvironment Using AXTEX-4DTM for Accelerating Cancer Research and Drug Screening.
Baru A; Mazumder S; Kundu PK; Sharma S; Das Purkayastha BP; Khan S; Gupta R; Mehrotra Arora N
Asian Pac J Cancer Prev; 2022 Feb; 23(2):561-571. PubMed ID: 35225469
[TBL] [Abstract][Full Text] [Related]
20. The potential application of organoids in breast cancer research and treatment.
Ebrahimi N; Nasr Esfahani A; Samizade S; Mansouri A; Ghanaatian M; Adelian S; Shadman Manesh V; Hamblin MR
Hum Genet; 2022 Feb; 141(2):193-208. PubMed ID: 34713317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
